GSK1059615
GSK1059615 is a research compound that has been investigated in clinical trials for various cancers, including lymphoma, solid tumors, endometrial cancer, and metastatic breast cancer. It functions as a potent and selective PI3K inhibitor, with studies demonstrating its activity in both in vitro cellular assays and in vivo tumor models.
Product Specifications
CAS Number
958852-01-2
Product Name Alternative
Inhibit, mTOR, GSK1059615, GSK-1059615, GSK 1059615, Inhibitor, Mammalian target of Rapamycin, Apoptosis, PI3Kγ, PI3Kβ, PI3Kδ, PI3Kα, PI3K, Phosphoinositide 3-kinase
Field of Research
Cell Biology, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
DMSO:5 mg/mL (15 mM)
Smiles
O=C1NC (=O) \C (S1) =C\c1ccc2nccc (-c3ccncc3) c2c1
Molecular Formula
C18H11N3O2S
Molecular Weight
333.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FT300A0785C Pack of 100
Pack of 100 Filter Discs For Prefiltration, 785 Mm
Sign In for Pricing
View Details 
038692-ML750 100 µL
MUC15, CT (MUC15, Mucin-15) (MaxLight 750) discontinued
Sign In for Pricing
View Details TSW-00516-01 100 mg
Methyl 2-deoxy-2-N-phthalimido-β-D-glucopyranoside
Sign In for Pricing
View Details